Related Experiment Video
Updated: May 20, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Infectious bronchitis virus nucleoprotein specific CTL response is generated prior to serum IgG
Guangliang Liu1, Qun Wang, Nihong Liu
1The Key Laboratory of Veterinary Public Health, Ministry of Agriculture, State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of CAAS, Harbin, Heilongjiang 150001, China.
Live Infectious Bronchitis Virus (IBV) H52 vaccination primes chickens for rapid T cell immunity. This immunization effectively protects against subsequent virulent IBV M41 challenge, preventing disease and pathology.
Area of Science:
- Veterinary Virology
- Immunology
- Poultry Health
Background:
- Infectious Bronchitis (IB) is a highly contagious viral respiratory disease in chickens.
- Understanding the interplay between cellular and humoral immunity is crucial for effective IBV vaccine development.
Purpose of the Study:
- To investigate the immune response kinetics and protective efficacy of IBV H52 vaccination.
- To correlate immune responses with pathological changes following IBV challenge.
Main Methods:
- SPF chickens were vaccinated with live IBV H52 and challenged with IBV M41.
- Immune responses (serum IgG, T cell immunity via MHC I tetramer) and pathology were monitored post-vaccination and challenge.
- Chickens were sampled every three days for detailed analysis.
Main Results:
- T cell immunity developed faster than humoral immunity after H52 vaccination.
- IBV M41 challenge significantly increased serum IgG levels.
- Vaccinated chickens showed no clinical signs or significant pathology, unlike unvaccinated controls.
Conclusions:
- Live IBV H52 inoculation provides effective protection against virulent IBV challenge.
- The study highlights the importance of T cell responses in IBV immunity.
- Findings support the development of next-generation IBV vaccines.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Vaccinations

